92 related articles for article (PubMed ID: 19127081)
1. Selective killing of leukemia and lymphoma cells ectopically expressing hCGbeta by a conjugate of curcumin with an antibody against hCGbeta subunit.
Vyas HK; Pal R; Vishwakarma R; Lohiya NK; Talwar GP
Oncology; 2009; 76(2):101-11. PubMed ID: 19127081
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin beta.
Yu N; Xu W; Jiang Z; Cao Q; Chu Y; Xiong S
Immunol Lett; 2007 Dec; 114(2):94-102. PubMed ID: 17964664
[TBL] [Abstract][Full Text] [Related]
3. A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low-dose interleukin 2 in acute myelogenous leukemia.
Kossman SE; Scheinberg DA; Jurcic JG; Jimenez J; Caron PC
Clin Cancer Res; 1999 Oct; 5(10):2748-55. PubMed ID: 10537338
[TBL] [Abstract][Full Text] [Related]
4. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
[TBL] [Abstract][Full Text] [Related]
5. The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.
Tanaka M; Kano Y; Akutsu M; Tsunoda S; Izumi T; Yazawa Y; Miyawaki S; Mano H; Furukawa Y
Anticancer Res; 2009 Nov; 29(11):4589-96. PubMed ID: 20032408
[TBL] [Abstract][Full Text] [Related]
6. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma.
Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC
Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885
[TBL] [Abstract][Full Text] [Related]
7. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
Nguyen DH; Ball ED; Varki A
Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
[TBL] [Abstract][Full Text] [Related]
8. CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance.
Linenberger ML
Leukemia; 2005 Feb; 19(2):176-82. PubMed ID: 15592433
[TBL] [Abstract][Full Text] [Related]
9. Development of a recombinant hCG-specific single chain immunotoxin cytotoxic to hCG expressing cancer cells.
Nand KN; Gupta JC; Panda AK; Jain SK
Protein Expr Purif; 2015 Feb; 106():10-7. PubMed ID: 25448825
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of human chorionic gonadotropin causes multiple reproductive defects in transgenic mice.
Matzuk MM; DeMayo FJ; Hadsell LA; Kumar TR
Biol Reprod; 2003 Jul; 69(1):338-46. PubMed ID: 12672665
[TBL] [Abstract][Full Text] [Related]
11. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
12. Fusion of hC3d3 to hCGbeta enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge.
Li HP; He XJ; Tang CL; Yao XY; Li DJ
J Reprod Immunol; 2008 Jul; 78(2):115-24. PubMed ID: 18479753
[TBL] [Abstract][Full Text] [Related]
13. Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice.
Ferretti E; Montagna D; Di Carlo E; Cocco C; Ribatti D; Ognio E; Sorrentino C; Lisini D; Bertaina A; Locatelli F; Pistoia V; Airoldi I
Leukemia; 2012 Feb; 26(2):225-35. PubMed ID: 21844875
[TBL] [Abstract][Full Text] [Related]
14. Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers.
Matsui H; Takeshita A; Naito K; Shinjo K; Shigeno K; Maekawa M; Yamakawa Y; Tanimoto M; Kobayashi M; Ohnishi K; Ohno R
Leukemia; 2002 May; 16(5):813-9. PubMed ID: 11986941
[TBL] [Abstract][Full Text] [Related]
15. [Long-term complete remission after single therapy with gemtuzumab ozogamicin for refractory AML in an elderly patient].
Ogura K; Machida T; Nara M; Mayama K; Akagi T; Kubo K
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1881-3. PubMed ID: 18030030
[TBL] [Abstract][Full Text] [Related]
16. Identification of cross-reactive and restricted epitopes localized on human chorionic gonadotropin beta-subunit by monoclonal antibodies.
Saboor-Yaraghi AA; Ghods R; Gharagozlou S; Roohi A; Khoshnoodi J; Towfighi F; Jeddi-Tehrani M; Shokri F
Hybrid Hybridomics; 2004 Apr; 23(2):101-7. PubMed ID: 15165483
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immunogenicity of a single chain chimeric peptide composed of hCGβ and oLHα for inhibition of the growth of hCGβ-expressing cancer cells.
Jiang C; Jiang Y; Huang Z; Shen W; Wang J; Shen Q
Cancer Immunol Immunother; 2010 Dec; 59(12):1771-9. PubMed ID: 20809357
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Roman E; Cooney E; Harrison L; Militano O; Wolownik K; Hawks R; Foley S; Satwani P; Unal E; Bhatia M; Bradley B; Del Toro G; George D; Garvin J; van de Ven C; Cairo MS
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7164s-7170s. PubMed ID: 16203817
[TBL] [Abstract][Full Text] [Related]
19. Nonassembled human chorionic gonadotropin subunits and alphaalpha-homodimers use fast-track processing in the secretory pathway in contrast to alphabeta-heterodimers.
Merz WE; Krause JM; Roig J; Singh V; Berger P
Endocrinology; 2007 Dec; 148(12):5831-41. PubMed ID: 17761764
[TBL] [Abstract][Full Text] [Related]
20. Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies.
Caron PC; Co MS; Bull MK; Avdalovic NM; Queen C; Scheinberg DA
Cancer Res; 1992 Dec; 52(24):6761-7. PubMed ID: 1458463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
